USD 94.92
(0.03%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 6.91 Billion | 6.06 Billion | 2.06 Billion | -4.13 Billion | 6.9 Billion | 6.16 Billion |
Net Income | 2.61 Billion | 737 Million | -1.96 Billion | -7.06 Billion | 3 Billion | 2.12 Billion |
Depreciation & Amortization | 2.81 Billion | 2.45 Billion | 2.48 Billion | 2.48 Billion | 2.28 Billion | 2.16 Billion |
Deferred income taxes | 756 Million | 248 Million | -583 Million | -1.74 Billion | 882 Million | 512 Million |
Stock-based compensation | 80 Million | 89 Million | 238 Million | 108 Million | 100 Million | 101 Million |
Change in working capital | 475 Million | 2.25 Billion | 1.67 Billion | 227 Million | 523 Million | 783 Million |
Other non-cash items | 928 Million | 4.64 Billion | 4.89 Billion | 7.88 Billion | 4.41 Billion | 4.76 Billion |
Investing Cash Flow | -6.1 Billion | -13.82 Billion | -1.67 Billion | 50 Million | -4.56 Billion | -4.45 Billion |
Investments in PPE | -7.17 Billion | -4.81 Billion | -2.1 Billion | -1.72 Billion | -4.52 Billion | -4.07 Billion |
Acquisitions | 39 Million | 207 Million | 107 Million | - | - | - |
Investment purchases | -9.47 Billion | -11.23 Billion | -68 Million | -552 Million | -2.93 Billion | -2.69 Billion |
Sales/Maturities of investments | 10.51 Billion | 2.08 Billion | 397 Million | 2.31 Billion | 2.99 Billion | 2.61 Billion |
Other Investing Activities | 1.06 Billion | -69 Million | -1 Million | 10 Million | -95 Million | -310 Million |
Financing Cash Flow | -1.89 Billion | -3.34 Billion | 6.39 Billion | 12.95 Billion | -1.28 Billion | -1.5 Billion |
Debt repayment | -1.86 Billion | -3.27 Billion | -5.89 Billion | -11.22 Billion | -395 Million | -249 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | -353 Million | -1.64 Billion | -1.23 Billion |
Common Stock Issuance | - | - | 532 Million | 2.1 Billion | - | - |
Other Financing Activities | -32 Million | -74 Million | -27 Million | -20 Million | -30 Million | -17 Million |
Accounts receivables | -100 Million | -158 Million | -448 Million | 135 Million | 44 Million | 17 Million |
Accounts payables | 572 Million | 796 Million | 985 Million | -1.07 Billion | 324 Million | 130 Million |
Inventory | - | - | - | - | - | - |
Other working capital | 575 Million | 1.61 Billion | 1.13 Billion | 1.17 Billion | 155 Million | 636 Million |
Cash at beginning of period | 7.42 Billion | 18.32 Billion | 11.52 Billion | 2.76 Billion | 1.69 Billion | 1.5 Billion |
Cash at end of period | 6.33 Billion | 7.21 Billion | 18.32 Billion | 11.52 Billion | 2.76 Billion | 1.69 Billion |
Capital Expenditure | -7.17 Billion | -4.81 Billion | -2.1 Billion | -1.72 Billion | -4.52 Billion | -4.07 Billion |
Effect of forex changes on cash | -35 Million | - | - | - | - | - |
Net cash flow / Change in cash | -1.08 Billion | -11.1 Billion | 6.79 Billion | 8.76 Billion | 1.06 Billion | 194 Million |
Free Cash Flow | -260 Million | 1.24 Billion | -40 Million | -5.86 Billion | 2.38 Billion | 2.09 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 965 Million | 1.32 Billion | -124 Million | 600 Million | 2.61 Billion | 1.13 Billion |
Depreciation & Amortization | 742 Million | 719 Million | 708 Million | 684 Million | 2.67 Billion | 663 Million |
Deferred income taxes | - | - | - | -1.92 Billion | 756 Million | - |
Stock-based compensation | - | - | - | 80 Million | 80 Million | - |
Change in working capital | - | - | - | 475 Million | 664 Million | - |
Other non-cash items | -209 Million | 834 Million | 3.67 Billion | -826 Million | 5.07 Billion | 406 Million |
Investing Cash Flow | -2.51 Billion | 134 Million | 1.44 Billion | -743 Million | -6.1 Billion | -1.93 Billion |
Investments in PPE | -1.41 Billion | -1.16 Billion | -1.36 Billion | -2.06 Billion | -7.17 Billion | -1.84 Billion |
Acquisitions | 24 Million | 22 Million | 20 Million | 19 Million | 39 Million | 11 Million |
Investment purchases | -2.3 Billion | -888 Million | -866 Million | -595 Million | -9.47 Billion | -1.99 Billion |
Sales/Maturities of investments | 1.38 Billion | 2.16 Billion | 3.65 Billion | 1.9 Billion | 10.51 Billion | 1.91 Billion |
Other Investing Activities | -208 Million | 1.29 Billion | -4 Million | -6 Million | -23 Million | -18 Million |
Financing Cash Flow | -1.07 Billion | -580 Million | -1.93 Billion | -123 Million | -1.89 Billion | -715 Million |
Debt repayment | -991 Million | -579 Million | -1.92 Billion | -122 Million | -1.86 Billion | -715 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -82 Million | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -1 Million | -18 Million | -1 Million | -32 Million | - |
Accounts receivables | - | - | - | -100 Million | -100 Million | - |
Accounts payables | - | - | - | - | 572 Million | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | 575 Million | 192 Million | - |
Cash at beginning of period | 10.89 Billion | 8.68 Billion | 6.08 Billion | 7.87 Billion | 7.21 Billion | 9.64 Billion |
Cash at end of period | 8.84 Billion | 11.11 Billion | 8.44 Billion | 6.08 Billion | 6.08 Billion | 7.87 Billion |
Capital Expenditure | -1.41 Billion | -1.16 Billion | -1.36 Billion | -2.06 Billion | -7.17 Billion | -1.84 Billion |
Effect of forex changes on cash | - | - | 2 Million | -5 Million | -35 Million | -2 Million |
Net cash flow / Change in cash | -2.04 Billion | 2.42 Billion | 2.35 Billion | -1.78 Billion | -1.12 Billion | -1.77 Billion |
Free Cash Flow | 88 Million | 1.71 Billion | 1.48 Billion | -2.97 Billion | -260 Million | -962 Million |
002713
LPE
3179
LRKKF
BPLPHARMA
3091